skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Development of complications of gestation in pregnant women with preeclampsia associated with thrombophilia

Medychni perspektyvy, 2016-01, Vol.21 (1), p.64-70 [Peer Reviewed Journal]

Copyright SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine" 2016 ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2307-0404 ;EISSN: 2307-0404 ;DOI: 10.26641/2307-0404.2016.1.63477

Full text available

  • Title:
    Development of complications of gestation in pregnant women with preeclampsia associated with thrombophilia
  • Author: Loskutova, T O
  • Subjects: antiphospholipid antibodies ; gene polymorphism ; Health risk assessment ; Homocysteine ; obstetric and perinatal complications ; Obstetrics ; pre-eclampsia ; Preeclampsia ; Pregnancy
  • Is Part Of: Medychni perspektyvy, 2016-01, Vol.21 (1), p.64-70
  • Description: In order to determine the impact of acquired, inherited, and combined multigenic thrombophilia in the development of obstetric and perinatal complications in preeclampsia, 133 women in the second and third trimesters of pregnancy were examined. 46 pregnant women with pre-eclampsia and obstetric and/or perinatal complications were included in the main group. Placentae abruption - 8.7%, eclampsia - 2,17%, HELLP- syndrome - 2.17%, FGR - 50.0%, antenatal fetal death - 13.04%, fetal distress during pregnancy - 45.65% were considered as complications. 87 pregnant women with preeclampsia, but without above mentioned complications formed group of comparison. The method of allele-specific polymerase chain reaction was performed to determine polymorphisms in the genes of factor V Leiden 1691 G → A, prothrombin 20210 G → A, plasminogen activator inhibitor type-1 5G / 4G, fibrinogen β 455 G → A, paraoxonase-1 192 Q → R, methylenetetrahydrofolate reductase (MTHFR) 677 C → T and angiotensinogen 235 M → T. To determine the causes of acquired thrombophilia antiphospholipid antibody level and concentration of homocysteine in plasma (ELISA) were studied.There were determined factors that increase relative risk of obstetric and perinatal complications in pregnant women with pre-eclampsia: first delivery, the onset of symptoms of preeclampsia at term less than 28 weeks of pregnancy, severe or moderately severe forms of preeclampsia, the duration of pre-eclampsia more than 5 weeks. Such genotypes as 1691 GA of Factor V Leiden - increases the risk by in 2.9 times (95% CI 1,94-4,33); prothrombin 20210 GA -by 2.36 times (95% CI: 1,54-3,6); prothrombin 20210 AA -by 3.12 times (95% CI 2,4-4,0) a combination of three or more pathologic polymorphisms -by 2.58 times (95% CI 1,64-4,05); pathological level of AFA -by 1.7 times (95% CI 1,08-2,67); combined thrombophilia -by 1.76 times (95% CI 1,12-2,76); homocysteine concentration of more than 15 µmol/l -by 2.31 times (95% CI 1.5-3.5) aremarkers of predisposition to the development of obstetric and perinatal complications in pregnant women with pre-eclampsia
  • Publisher: Dnipropetrovsk: Dnipro State Medical University
  • Language: English;Russian;Ukrainian
  • Identifier: ISSN: 2307-0404
    EISSN: 2307-0404
    DOI: 10.26641/2307-0404.2016.1.63477
  • Source: ProQuest Central
    DOAJ Directory of Open Access Journals

Searching Remote Databases, Please Wait